Hepatitis C treatment initiation found to be low among Medicaid recipients

FHS
August 8, 2023
12:12 pm

While there are highly effective treatments for the hepatitis C virus (HCV), only 1 in 5 Medicaid enrollees diagnosed with HCV started treatment, according to a retrospective study led by researchers at Weill Cornell Medicine and Cornell University’s Ithaca campus.

Automated Insulin Pump Helps Type 2 Diabetes Control

ORLANDO — Putting type 2 diabetes patients on an automated insulin delivery (AID) pump improved glycemic control, the SECURE-T2D pivotal trial showed. Type 2 diabetes

June 24, 2024

FDA reports shortage of Novo Nordisk’s weight loss drug Saxenda

Novo Nordisk is facing another shortage of one of its blockbuster drugs; this time it’s the weight loss drug liraglutide, better known as Saxenda. According

July 21, 2023

Roche was in ‘advanced’ talks to out-license its Angelman syndrome drug, but potential partner withdrew

Roche is back to square one for finding a partner to carry forward its culled Angelman syndrome drug. Last June, the Swiss pharma had started

May 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.